Related Experiment Video
Updated: May 14, 2026

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Contemporary management of tricuspid regurgitation: an updated clinical review
Joshua T Taylor1, Geoffrey Chidsey, Thomas G Disalvo
1Division of Cardiovascular Surgery, Vanderbilt University Medical Center, Vanderbilt Heart and Vascular Institute, Nashville, TN 37232-8802, USA.
Abstract:
Tricuspid regurgitation (TR) is a complex and insidious valvular pathology that represents a complex decision and management algorithm for patients. TR is present in a significant proportion of the population and is especially prevalent in patients with advanced heart failure. Patients with TR have been demonstrated to have a decreased survival even with normal left heart function. TR can be a result of pathology that directly affects the valvular structure (i.e., Ebstein anomaly) or as a result of increased forward pressures (ie, pulmonary hypertension, left heart failure). Conservative management of patients with TR is primarily symptomatic relief. Definitive therapy involves surgical repair of the tricuspid valve. Furthermore, as more patients develop advanced heart failure, the management of TR in patients with left ventricular assist devices has become necessary because of the evidence of increased in-hospital morbidity and a trend toward decreased survival.
Related Concept Videos
Mitral Regurgitation III: Medical Management
Aortic Regurgitation III: Medical Management
Mitral Regurgitation IV: Nursing Management
Mitral Stenosis III: Medical Management
Aortic Regurgitation IV: Nursing Management
Mitral Valve Prolapse II: Assessment and Management
